Effects of low-dose bisphenol A on DNA damage and proliferation of breast cells: The role of c-Myc

Environmental Health Perspectives

Volumn 123, Issue 12, 2015, Pages 1271-1279

  Pfeifer, Daniella ^a   Chung, Young Min ^a   Hu, Mickey C T ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; BENZHYDRYL DERIVATIVE; ESTROGEN RECEPTOR ALPHA; MYC PROTEIN; PHENOL DERIVATIVE; POLLUTANT; SMALL INTERFERING RNA;

CELL LINE; CELL PROLIFERATION; CYTOLOGY; DNA DAMAGE; DRUG EFFECTS; FEMALE; GENE SILENCING; GENETICS; HUMAN; MAMMARY GLAND; METABOLISM; ONCOGENE MYC; POLLUTANT; TOXICITY; TUMOR CELL LINE; UPREGULATION;

BENZHYDRYL COMPOUNDS; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; DNA DAMAGE; ENVIRONMENTAL POLLUTANTS; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE SILENCING; GENES, MYC; HUMANS; MAMMARY GLANDS, HUMAN; PHENOLS; PROTO-ONCOGENE PROTEINS C-MYC; RNA, SMALL INTERFERING; UP-REGULATION;

EID: 84947293308     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1409199     Document Type: Article

References (40)

1. Audebert M, Dolo L, Perdu E, Cravedi JP, Zalko D. 2011. Use of the yH2AX assay for assessing the genotoxicity of bisphenol A and bisphenol F in human cell lines. Arch Toxicol 85:1463-1473.
2. Ayyanan A, Laribi O, Schuepbach-Mallepell S, Schrick C, Gutierrez M, Tanos T, et al. 2011. Perinatal exposure to bisphenol A increases adult mammary gland progesterone response and cell number. Mol Endocrinol 25:1915-1923.
3. Bakkenist CJ, Kastan MB. 2004. Initiating cellular stress responses. Cell 118:9-17.
4. Boyd M, Hildebrandt RH, Bartow SA. 1996. Expression of the estrogen receptor gene in developing and adult human breast. Breast Cancer Res Treat 37:243-251.
5. Calafat AM, Kuklenyik Z, Reidy JA, Caudill SP, Ekong J, Needham JL. 2005. Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ Health Perspect 113:391-395 doi:10.1289/ehp.7534.
6. Cavalieri EL, Rogan EG. 2010. Is bisphenol A a weak carcinogen like the natural estrogens and diethyl-stilbestrol? IUBMB Life 62:746-751.
7. Chung YM, Park SH, Tsai WB, Wang SY, Ikeda MA, Berek JS, et al. 2012. FOXO3 signalling links ATM to the p53 apoptotic pathway following DNA damage. Nat Commun 3:1000; doi:10.1038/ncomms2008.
8. Cowling VH, D’Cruz CM, Chodosh LA, Cole MD. 2007. c-Myc transforms human mammary epithelial cells through repression of the Wnt inhibitors DKK1 and SFRP1. Mol Cell Biol 27:5135-5146.
9. Dairkee SH, Luciani-Torres MG, Moore DH, Goodson WH III. 2013. Bisphenol-A-induced inactivation of the p53 axis underlying deregulation of proliferation kinetics, and cell death in non-malignant human breast epithelial cells. Carcinogenesis 34:703-712.
10. Dairkee SH, Seok J, Champion S, Sayeed A, Mindrinos M, Xiao W, et al. 2008. Bisphenol A induces a profile of tumor aggressiveness in high-risk cells from breast cancer patients. Cancer Res 68:2076-2080.
11. Diel P, Olff S, Schmidt S, Michna H. 2002. Effects of the environmental estrogens bisphenol A, o,p’-DDT, p-fert-octylphenol and coumestrol on apoptosis induction, cell proliferation and the expression of estrogen sensitive molecular parameters in the human breast cancer cell line MCF-7. J Steroid Biochem Mol Biol 80:61-70.
12. Dong S, Terasaka S, Kiyama R. 2011. Bisphenol A induces a rapid activation of Erk1/2 through GPR30 in human breast cancer cells. Environ Pollut 159:212-218.
13. Fenichel P, Chevalier N, Brucker-Davis F. 2013. Bisphenol A: an endocrine and metabolic disruptor. Ann Endocrinol (Paris) 74:211-220.
14. Hanahan D, Weinberg RA. 2011. Hallmarks of cancer: the next generation. Cell 144:646-674.
15. Hu T, Chung YM, Guan M, Ma M, Ma J, Berek JS, et al. 2014. Reprogramming ovarian and breast cancer cells into non-cancerous cells by low-dose metformin or SN-38 through FOXO3 activation. Sci Rep 4:5810; doi:10.1038/srep05810.
16. Kastan MB, Bartek J. 2004. Cell-cycle checkpoints and cancer. Nature 432:316-323.
17. Keri RA, Ho SM, Hunt PA, Knudsen KE, Soto AM, Prins GS. 2007. An evaluation of evidence for the carcinogenic activity of bisphenol A. Reprod Toxicol 24:240-252.
18. Kovacic P. 2010. How safe is bisphenol A? Fundamentals of toxicity: metabolism, electron transfer and oxidative stress. Med Hypotheses 75:1-4.
19. Kurosawa T, Hiroi H, Tsutsumi O, Ishikawa T, Osuga Y, Fujiwara T, et al. 2002. The activity of bisphenol A depends on both the estrogen receptor subtype and the cell type. Endocr J 49:465-471.
20. LaPensee EW, Tuttle TR, Fox SR, Ben-Jonathan N. Bisphenol A at low nanomolar doses confers chemoresistance in estrogen receptor-a-positive and -negative breast cancer cells. Environ Health Perspect 117:175-180; doi:10.1289/ehp.11788.
21. Lassen TH, Frederiksen H, Jensen TK, Petersen JH, Joensen UN, Main KM, et al. 2014. Urinary bisphenol A levels in young men: association with reproductive hormones and semen quality. Environ Health Perspect 122:478-484; doi:10.1289/ehp.1307309.
22. Li Z, Owonikoko TK, Sun SY, Ramalingam SS, Doetsch PW, Xiao ZQ, et al. 2012. c-Myc suppression of DNA double-strand break repair. Neoplasia 14:1190-1202.
23. Munoz-de-Toro M, Markey CM, Wadia PR, Luque EH, Rubin BS, Sonnenschein C, et al. 2005. Perinatal exposure to bisphenol A alters peri-pubertal mammary gland development in mice. Endocrinology 146:4138-4147.
24. Negrini S, Gorgoulis VG, Halazonetis TD. 2010. Genomic instability—an evolving hallmark of cancer. Nat Rev Mol Cell Biol 11:220-228.
25. Ogrunc M, Di Micco R, Liontos M, Bombardelli L, Mione M, Fumagalli M, et al. 2014. Oncogene-induced reactive oxygen species fuel hyperproliferation and DNA damage response activation. Cell Death Differ 21:998-1012.
26. Olsen CM, Meussen-Elholm ET, Samuelsen M, Holme JA, Hongslo JK. 2003. Effects of the environmental oestrogens bisphenol A, tetra-chlorobisphenol A, tetrabromobisphenol A, 4-hydroxybiphenyl and 4,4’-dihydroxybiphenyl on oestrogen receptor binding, cell proliferation and regulation of oestrogen sensitive proteins in the human breast cancer cell line MCF-7. Pharmacol Toxicol 92:180-188.
27. Park SH, Lee JH, Berek JS, Hu MC. 2014. Auranofin displays anticancer activity against ovarian cancer cells through FOXO3 activation independent of p53. Int J Oncol 45:1691-1698.
28. Peretz J, Vrooman L, Ricke WA, Hunt PA, Ehrlich S, Hauser R, et al. 2014. Bisphenol A and reproductive health: update of experimental and human evidence, 2007-2013. Environ Health Perspect 122:775-786; doi:10.1289/ehp.1307728.
29. Polyak K, Kalluri R. 2010. The role of the microenvironment in mammary gland development and cancer. Cold Spring Harb Perspect Biol 2:a003244; doi:10.1101/cshperspect.a003244.
30. Rochester JR. 2013. Bisphenol A and human health: a review of the literature. Reprod Toxicol 42:132-155.
31. Rothkamm K, Lobrich M. 2003. Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses. Proc Natl Acad Sci USA 100:5057-5062.
32. Samuelsen M, Olsen C, Holme JA, Meussen-Elholm E, Bergmann A, Hongslo JK. 2001. Estrogen-like properties of brominated analogs of bisphenol A in the MCF-7 human breast cancer cell line. Cell Biol Toxicol 17:139-151.
33. Schmidt EV. 1999. The role of c-myc in cellular growth control. Oncogene 18:2988-2996.
34. Tsai WB, Chung YM, Takahashi Y, Xu Z, Hu MC. 2008. Functional interaction between FOXO3a and ATM regulates DNA damage response. Nat Cell Biol 10:460-467.
35. Vafa O, Wade M, Kern S, Beeche M, Pandita TK, Hampton GM, et al. 2002. c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. Mol Cell 9:1031-1044.
36. Vandenberg LN, Chahoud I, Heindel JJ, Padmanabhan V, Paumgartten FJ, Schoenfelder G. Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A. Environ Health Perspect 118:1055-1070; doi:10.1289/ehp.0901716.
37. Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV. 2007. Human exposure to bisphenol A (BPA). Reprod Toxicol 24:139-177.
38. Weber Lozada K, Keri RA. 2011. Bisphenol A increases mammary cancer risk in two distinct mouse models of breast cancer. Biol Reprod 85:490-497.
39. Yi B, Kim C, Park M, Han Y, Park JY, Yang M. 2013. Association between endocrine disrupting phenols in colostrums and maternal and infant health. Int J Endocrinol 2013:282381; doi:10.1155/2013/282381.
40. Zhou BB, Elledge SJ. 2000. The DNA damage response: putting checkpoints in perspective. Nature 408:433-439.